KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Gross Margin (2016 - 2025)

Charles River Laboratories International has reported Gross Margin over the past 17 years, most recently at 74.93% for Q4 2025.

  • For Q4 2025, Gross Margin rose 11114.0% year-over-year to 74.93%; the TTM value through Dec 2025 reached 54.68%, up 1638.0%, while the annual FY2025 figure was 85.65%, 2755.0% up from the prior year.
  • Gross Margin for Q4 2025 was 74.93% at Charles River Laboratories International, up from 59.39% in the prior quarter.
  • Over five years, Gross Margin peaked at 210.64% in Q4 2021 and troughed at 36.22% in Q4 2024.
  • A 5-year average of 60.88% and a median of 47.66% in 2021 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: tumbled -16548bps in 2022 and later surged 11114bps in 2025.
  • Year by year, Gross Margin stood at 210.64% in 2021, then crashed by -79bps to 45.16% in 2022, then skyrocketed by 52bps to 68.57% in 2023, then plummeted by -153bps to 36.22% in 2024, then skyrocketed by 307bps to 74.93% in 2025.
  • Business Quant data shows Gross Margin for CRL at 74.93% in Q4 2025, 59.39% in Q3 2025, and 43.33% in Q2 2025.